Biochem/physiol Actions
Gastric proton pump inhibitor.
Features and Benefits
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This product has met the following criteria to qualify for the following awards: